Citation: E. Verspyck et al., Leuprorelin depot 3.75 mg versus lynestrenol in the preoperative treatmentof symptomatic uterine myomas: a multicentre randomised trial, EUR J OB GY, 89(1), 2000, pp. 7-13
Authors:
Verspyck, E
Le Cam-Duchez, V
Gravier, A
Descargues, G
Marpeau, L
Borg, JY
Citation: E. Verspyck et al., Small for gestational age infant in association with maternal prothrombin gene variant (nt 20210A), EUR J OB GY, 83(2), 1999, pp. 143-144
Authors:
Verspyck, E
Gaillard, G
Parnet, F
Marret, S
Marpeau, L
Citation: E. Verspyck et al., Fetal lactic dehydrogenase variation in normal pregnancy and in cases of severe intra-uterine growth restriction, PRENAT DIAG, 19(3), 1999, pp. 229-233
Authors:
Verspyck, E
Degre, S
Hellot, MF
Descargues, G
Philippe, C
Labadie, G
Benichou, J
Lemoine, JP
Marpeau, L
Citation: E. Verspyck et al., Amniotic fluid alpha-fetoprotein is not a useful biological marker of pregnancy outcome, PRENAT DIAG, 19(11), 1999, pp. 1031-1034